CD8A and neoplasm: In the absence of a tumor, there was no significant change in the levels of TRP2-specific CD3+CD8+ T lymphocytes in the peripheral blood lymphocyte (PBL), suggesting that PMG5 had an influence on the TME rather than directly affecting the efficacy of the cancer vaccine (fig.